☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
mirikizumab
Dr. Lotus Mallbris Discusses Positive Results from the VIVID-1 P-III Study of Mirikizumab for the Treatment of Crohn's Disease in...
December 20, 2023
PharmaShots Interview: Eli Lilly's Dr. Lotus Mallbris Shares Insights on Mirikizumab
November 3, 2020
Lilly Reports Results of Mirikizumab in P-ll SERENITY Study for Crohn's Disease
October 13, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.